Felix Kuhne

Felix studied Molecular Biotechnology at the Technical University of Munich (Germany) with his final thesis focusing on the conformational characteristics of amyloid precursor protein related peptides. Working in pharma bioprocess development at Genentech (South San Francisco) lay the groundwork for his current position as a PhD student at the University of Muenster (Germany) in cooperation with Roche Pharma (Penzberg). Here, he investigates structure to function relationships of antibody modifications.